Lead program
Neurodegeneration
De novo protein-binder program — Alzheimer’s disease
- Design & engineering
- Lead optimisation
- Preclinical
- IND-enabling
- Target
- Several critical targets in Alzheimer’s disease — we are developing multifunctional binders against them.
- Approach
- We apply large language models (LLMs) of artificial intelligence to engineer binders against specific targets and to develop multifunctional binders with greater pathological efficacy and potential for disease recovery.
- Stage
- Design & engineering